Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.
Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.
The regulation of the white-cell count is dependent upon many factors controlling production, maturation and release from the bone marrow, distribution in peripheral blood pools and egress to ...
Anemia can be treated with an iron-rich diet, iron supplements, or blood transfusions. White blood cells are a vital part of the body’s immune system. When chemotherapy significantly lowers ...
Blood blisters in the mouth usually result from accidental injury. Most respond to home treatment, such as a saltwater gargle, oil pulling with coconut oil, or over-the-counter (OTC) medication ...
Red blood cells (RBC) can be present in urine even when they are not visible to a person. Also known as hematuria, RBC in urine can indicate an infection, kidney disease, and other health conditions.
The purity of the cell lines was tested using a single-nucleus RNA sequencing (snRNA-seq) approach, which indicated no residual pluripotent stem cell contamination. EHM generated from rhesus ...
This important study reports single-nucleus multiomics-based profiling of transcriptome and chromatin accessibility of mouse XX and XY primordial germ cells (PGCs). The main conclusions of this study, ...
can also be located in the cell nucleus, where the genetic material resides. Remarkably, nuclear Talin-1 was shown to influence the expression of genes that regulate cell-to-cell connections.
With the proliferation of leukemic cells in the body, the symptoms of leukemia can become more unmistakable. As the number of white blood cells continues to drop, your ability to fight infection will ...
They found Phoenix Brown, 18, of Cleveland, leaving the scene, wearing clothes that were “covered in blood,” according ... Officers found 17-year-old Khalyn White and 16-year-old Julius ...
The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood cancer patients. Listen to Story Qartemi is India's second CAR-T cell therapy ...